pyrazines has been researched along with Mastocytosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aichberger, KJ; Baumgartner, C; Cerny-Reiterer, S; Ferenc, V; Gleixner, KV; Gruze, A; Kneidinger, M; Mayerhofer, M; Mirkina, I; Peter, B; Pickl, WF; Sillaber, C; Valent, P | 1 |
| Barete, S; Bodemer, C; Dubreuil, P; Georgin-Lavialle, S; Hermine, O; Lepelletier, Y; Lortholary, O; Suarez, F | 1 |
1 review(s) available for pyrazines and Mastocytosis, Systemic
| Article | Year |
|---|---|
[Current concepts and treatment advances in systemic mastocytosis].
Topics: Adult; Boronic Acids; Bortezomib; Child; Forecasting; Humans; Immunohistochemistry; Immunosuppressive Agents; Mastocytosis, Systemic; Mutation; Prognosis; Protease Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazines; Sirolimus; Stem Cell Transplantation; Transduction, Genetic; World Health Organization | 2009 |
1 other study(ies) available for pyrazines and Mastocytosis, Systemic
| Article | Year |
|---|---|
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Blotting, Northern; Blotting, Western; Boronic Acids; Bortezomib; Flow Cytometry; Gene Expression; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mast Cells; Mastocytosis, Systemic; Membrane Proteins; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Staurosporine; Transfection | 2009 |